Background & Aims Radiofrequency ablation (RFA) is an effective treatment for single
hepatocellular carcinoma (HCC)≤ 3 cm. Disease recurrence is common, and in some …

Objectives The purpose of this study was to evaluate the 10-year overall survival and local
tumor progression (LTP) of percutaneous radiofrequency ablation (RFA) for single nodular …

Background. The optimal therapy for hepatocellular carcinoma (HCC) is transplantation. For
all those patients not eligible for transplantation (or on the waiting list) among the treatments …

BACKGROUND Significant controversy exists as to which treatment modality is most
effective for small, solitary hepatocellular carcinomas (HCCs): radiofrequency ablation …

The incidence of hepatocellular carcinoma (HCC) is increasing in the United States.
Although liver transplantation is an effective means of treating selected patients …

Background Radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) is widely
utilized as a bridge to liver transplant with limited evidence to support efficacy. The purpose …

OBJECTIVE. The aims of this study were to determine the feasibility and efficacy of
percutaneous radiofrequency ablation in patients with hepatocellular carcinoma waiting for …

Objective This study aims to determine the risk factors, patterns, and long-term survival
outcomes of late recurrence after radiofrequency ablation (RFA) for hepatocellular …

Objectives: To evaluate the efficacy of surgical resection (SR) and radiofrequency ablation
(RFA) for single hepatocellular carcinoma (HCC) 2 cm or less. Background: The optimal …

BACKGROUND & AIMS: The aim of this study was to compare liver resection and
radiofrequency ablation in patients with single hepatocellular carcinoma⩽ 3cm and …